MedPath

VANIQA

VANIQA

Approved
DIN Number

02243837

Drug Class

Human

Market Date

Nov 1, 2005

Company
HC

Cipher Pharmaceuticals Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02243837
AIG Number0143801001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D11AX16 EFLORNITHINE
Product Specifications
Dosage FormCream
Route of AdministrationTopical
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

EFLORNITHINE HYDROCHLORIDEActive
Strength: 13.9 % / W/W
Monograph: EFLORNITHINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.